HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy

Cited by papers we hold 8

• A Comprehensive Review of HER2 in Cancer Biology and Therapeutics · 2024
  No notice
• Gastric cancer treatment: recent progress and future perspectives · 2023
  No notice
• Emerging Targeted Therapies for HER2-Positive Breast Cancer · 2023
  No notice
• Tumor Microenvironment in Breast Cancer—Updates on Therapeutic Implications and Pathologic Assessment · 2021
  No notice
• CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment · 2021
  No notice
• Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy · 2021
  No notice
• Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer · 2020
  No notice
• More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.